Impact of monoclonal antibody therapy for head and neck cancer on end‐of‐life care utilization and costs.
- Resource Type
- Article
- Source
- Head & Neck; Jun2023, Vol. 45 Issue 6, p1468-1475, 8p
- Subject
HEAD & neck cancer TERMINAL care MONOCLONAL antibodies MEDICAL care use CANCER treatment CANCER patient care CRITICALLY ill patient care - Language
- ISSN
- 10433074